Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
The Pharmaceutical Market: Lebanon

Lebanon pharmaceutical market: Latest market analysis presented


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-13 14:56:05 - The Pharmaceutical Market: Lebanon - a new market research report on companiesandmarkets.com

Although this quarter has seen a number of regulatory initiatives taken by the Lebanese Minister of Health, Ali Hassan Khalil , to improve the state of the pharmaceutical industry, we maintain that a multilateral approach is required to improve foreign direct investment (FDI) in to the country and that , in the short to medium term, investment will be deterred and medical tourism revenue diminished by wider macroeconomic and political vulnerabilit i es. Nonetheless, BMI holds to the view that the country provides stable opportunities for multinationals to tap into the cultural prioritisation for medicines and benefit from the increasingly - urbanized population, although risk s include a relatively weak regulatory framework, poor intellectual property laws and medicine pricing restrictions.

Headline

 

 

Expenditure Projections

Pharmaceuticals: LBP1,959bn (US$1.30bn) in 2011 to LBP2,061bn (US$1.37bn) in 2012; +8.6% in local currency terms and +9.2% in US dollar terms. Forecast revised upwards from Q4 12 due to modifications to historical figures.

Healthcare: LBP4,495bn (US$2.99bn) in 2011 to LBP4,750bn (US$3.15bn) in 2012; +5.7% in local currency terms and +5.6% in US dollar terms. Forecast revised upwards from Q4 12 due to modifications to historical figures.

Medical Devices: LBP365.26bn (US$243mn) in 2011 to LBP402.84bn (US$267mn) in 2012; +10.3% in local currency terms and +10.2% in US dollar terms. Forecast revised downwards from Q4 12 due to modifications to historical figures.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com